Glycemic Control and Complication Prevention in Diabetes Mellitus
Core Glycemic Targets
- The American Diabetes Association recommends a standard target of HbA1c <7% (53 mmol/mol) for most non-pregnant adults with diabetes, as this level reduces microvascular complications and mortality 1
- A more stringent target of HbA1c <6.5% (48 mmol/mol) may be appropriate for selected patients with short duration of diabetes, type 2 diabetes treated with lifestyle or metformin only, long life expectancy, or no significant cardiovascular disease 2
- A less stringent target of HbA1c <8% (64 mmol/mol) is appropriate for patients with history of severe hypoglycemia, limited life expectancy, advanced microvascular or macrovascular complications, extensive comorbid conditions, or long-standing diabetes that is difficult to control 1, 4
Prevention Goals for Prediabetes
- The American Diabetes Association recommends weight loss of ≥7% reduction of initial body weight through intensive lifestyle behavior change programs for individuals with prediabetes 6
- Physical activity of ≥150 minutes per week of moderate-intensity activity is recommended for individuals with prediabetes 6
- A reduced-calorie diet with 500-1,000 calories/day reduction depending on initial body weight, focusing initially on reducing total fat, is recommended for individuals with prediabetes 6
Individualization Framework
- Glycemic goals must be individualized through shared decision-making, considering factors such as age, disease duration, life expectancy, hypoglycemia risk, comorbidities, and treatment burden 1, 4
- The American Diabetes Association emphasizes considering multiple factors simultaneously when individualizing glycemic goals 1, 4
Hypoglycemia Prevention and Management
- Level 1 hypoglycemia is defined as glucose <70 mg/dL (3.9 mmol/L), and treatment with fast-acting carbohydrates is recommended 5
- Level 2 hypoglycemia is defined as glucose <54 mg/dL (3.0 mmol/L), and immediate treatment is required 5
- Level 3 hypoglycemia is defined as altered mental/physical status requiring assistance, and may require glucagon administration 5
Long-Term Complication Prevention
- Intensive glycemic control has been proven to reduce microvascular complications such as retinopathy, nephropathy, and neuropathy 1, 4
- Long-term follow-up demonstrates a 57% reduction in cardiovascular events with intensive management in type 1 diabetes, and reductions in myocardial infarctions and mortality in type 2 diabetes 1, 4
- The legacy effect of intensive glucose lowering extends for decades after the intensive period ends 1, 4